Cataract & Refractive

New cataract and refractive options from STAAR Surgical could come as early as this year

Two members of the team gave a preview of Geuder’s 2024 spotlight products

The diagnostic imaging experts will provide education through the Cybersight platform

At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.

Lenticule extraction poses a provocative question–and a complicated answer

According to the company, the deal expands its European footprint into Spain and Portugal.

Advancements from Carl Zeiss Medical AG in the cataract and cornea space include a new intraocular lens and therapeutic laser enhancements.

The new platform incorporates the SILK procedure, allowing surgeons to perform refractive correction on patients with myopia.

The EUREQUO Annual Report celebrates 15 years and over 4 million surgical procedures in the registry.

Eva Kim, MD, spoke with our team to share insights from her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.

A multicentre study demonstrates comparable results to FS-LASIK

This year’s meeting will include boxing rings, ball gowns and a full schedule of engaging new symposia

Investigators found that implementing immediately sequential bilateral cataract surgery reduced the number of patient visits by 50%.

Orbis International physician spotlights the latest trends for cataract surgery training.

A look at how EDOF technology can be categorised into five types

Novel procedures may hold greater appeal for cataract and refractive surgeons

Dr Arun C. Gulani explains how his corneal surface technique offers a contrast to cutting procedures without risk, pain or drama.

The announcement represents the first FDA-approved, fixed-combination of tropicamide and phenylephrine for mydriasis, according to the company.

The company’s CT Lucia 621P monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimised visual outcomes.

The atropine drops did not cause significant changes in the near vision or the pupillary size, according to study investigators.

Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.

As the company marks its 40-year anniversary, the new rebranding will become official on March 10, 2023, and will be followed by the introduction of new products.

The technology will be available soon for ophthalmologists in select countries across Asia Pacific and Europe.

The procedure facilitates an independent life, better care and fewer costs.

Prompt intervention may reduce treatment burden and improve the prognosis of fungal endophthalmitis after cataract surgery.